S M Bode - JoVE Visualize

Showing results (11-20 of 62) with videos related to

Pageof 7

Sort By:

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1998

Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitroS M Bode-Böger, R H Böger, A Galland, et al.

Cardiovascular Research|April 1, 1994

Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in ratsR H Böger, S M Bode-Böger, U Gerecke, et al.

European Heart Journal|November 1, 1989

Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteriesU Förstermann, A Mügge, U Alheid, et al.

European Journal of Clinical Pharmacology|January 29, 1999

Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjectsS M Bode-Böger, R H Böger, M Schubert, et al.

Journal of Cardiovascular Risk|August 1, 1994

Exercise increases systemic nitric oxide production in menS M Bode-Böger, R H Böger, E P Schröder, et al.

Life Sciences|May 4, 2000

L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrixR P Brandes, S Brandes, R H Böger, et al.

Kidney International|October 1, 1996

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoidsS M Bode-Böger, R H Böger, M Kuhn, et al.

British Journal of Clinical Pharmacology|December 2, 1998

L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationshipS M Bode-Böger, R H Böger, A Galland, et al.

FEBS Letters|August 3, 2000

Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradoxD Tsikas, R H Böger, J Sandmann, et al.

Journal of Cardiovascular Pharmacology|January 1, 1992

Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietinS M Bode-Böger, R H Böger, M Kuhn, et al.

Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:

Pageof 7

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1998

Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitroS M Bode-Böger, R H Böger, A Galland, et al.

Cardiovascular Research|April 1, 1994

Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in ratsR H Böger, S M Bode-Böger, U Gerecke, et al.

European Heart Journal|November 1, 1989

Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteriesU Förstermann, A Mügge, U Alheid, et al.

European Journal of Clinical Pharmacology|January 29, 1999

Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjectsS M Bode-Böger, R H Böger, M Schubert, et al.

Journal of Cardiovascular Risk|August 1, 1994

Exercise increases systemic nitric oxide production in menS M Bode-Böger, R H Böger, E P Schröder, et al.

Life Sciences|May 4, 2000

L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrixR P Brandes, S Brandes, R H Böger, et al.

Kidney International|October 1, 1996

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoidsS M Bode-Böger, R H Böger, M Kuhn, et al.

British Journal of Clinical Pharmacology|December 2, 1998

L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationshipS M Bode-Böger, R H Böger, A Galland, et al.

FEBS Letters|August 3, 2000

Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradoxD Tsikas, R H Böger, J Sandmann, et al.

Journal of Cardiovascular Pharmacology|January 1, 1992

Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietinS M Bode-Böger, R H Böger, M Kuhn, et al.

Pageof 7